Parkinson’s disease is a long-term brain condition that affects movement, balance, and daily life. It happens when certain ...
Phase 2 data from PTC Therapeutics showed that the Novartis-partnered Huntington’s disease asset slowed progression by more ...
Parkinson’s disease is a condition that slowly affects the brain and makes movement harder over time. People with Parkinson’s ...
This is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved ...
A new drug targeting triple-negative breast cancer overwhelms cancer cells with fat-like molecules called ceramides ...
Trendonomist on MSN
Health Canada approves second drug to slow Alzheimer’s
Health Canada’s approval of a second drug that can slow Alzheimer’s marks one of the most consequential moments Canada has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results